Nanobiotix Announces Current Voting Rights and Share Capital

Nanobiotix has disclosed its voting rights and share capital details as of October 31, 2026. The company reports 50,968,893 shares are currently outstanding. The total theoretical voting rights reach 54,726,179, while the total exercisable voting rights amount to 54,704,061. These figures are released in compliance with the French Commercial Code and the French Financial Markets Authority regulations.

Nanobiotix, listed on both Euronext Paris and Nasdaq, continues its focus on innovative biotechnology solutions. The update is part of ongoing efforts to maintain transparency with shareholders and the public regarding the company's financial status.